BDSX vs CSTL: stock comparison and AI forecast
Biodesix Inc (BDSX) and Castle Biosciences Inc (CSTL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BDSX Biodesix Inc
- Price
- $21.49 +43.3% · 6M
- Market Cap
- $227M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
CSTL Castle Biosciences Inc
- Price
- $35.75 +44.4% · 6M
- Market Cap
- $1.09B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- CSTL is 4.8 times larger than BDSX by market capitalization ($1.09B against $227M).
- Over the last six months CSTL returned +44.4% and BDSX +43.3%.
- CSTL turns -5.4% of its revenue into net income, against -27.0% for BDSX.
- BDSX carries 9.42 times debt per unit of equity, against 0.19 times for CSTL.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BDSX | CSTL |
|---|---|---|
| Market Cap | $227M | $1.09B |
| P/B Ratio | 24.80x | 2.32x |
| EPS | $-2.18 | $-1.05 |
| Book Value/Share | $0.87 | $15.39 |
| Revenue/Share | $9.76 | $11.70 |
| FCF/Share | $-1.92 | $-0.02 |
Profitability & Margins
| Metric | BDSX | CSTL |
|---|---|---|
| ROE | -303.6% | -4.1% |
| ROA | -29.1% | -3.5% |
| ROIC | -25.8% | -6.4% |
| Gross Margin | – | 77.3% |
| Operating Margin | -20.0% | -9.0% |
| Net Margin | -27.0% | -5.4% |
| EBT Margin | -20.0% | -9.0% |
| Tax Rate | 0.0% | -0.7% |
Financial Health
| Metric | BDSX | CSTL |
|---|---|---|
| Current Ratio | 2.85x | 6.04x |
| Quick Ratio | – | 5.85x |
| D/E Ratio | 9.42x | 0.19x |
| Financial Leverage | 10.42x | 1.19x |
| Interest Coverage | -2.7x | -16.6x |
| Working Capital | $28M | $285M |
Cash Flow
| Metric | BDSX | CSTL |
|---|---|---|
| Operating Cash Flow | -$20M | $43M |
| Free Cash Flow | -$20M | -$490K |
| Capital Spending | -$410K | -$43M |
| OCF Growth YoY | – | -31.8% |
| FCF Growth YoY | – | -101.4% |
| FCF/Sales | -19.7% | -0.1% |
| CapEx/Sales | 0.4% | 12.1% |
Operational Efficiency
| Metric | BDSX | CSTL |
|---|---|---|
| Asset Turnover | 1.08x | 0.64x |
| Receivables Turnover | 11.3x | 7.4x |
| Inventory Turnover | – | 7.7x |
| Fixed Assets Turnover | 4.3x | 3.4x |
| Days Sales Outstanding | 32 days | 49 days |
| Days Inventory | – | 48 days |
| Payables Period | – | 43 days |
| Cash Conversion Cycle | – | 53 days |
Income Statement
| Metric | BDSX | CSTL |
|---|---|---|
| Total Revenue | $103M | $357M |
| Operating Income | -$21M | -$32M |
| Net Income | -$28M | -$19M |
| R&D Expense | $12M | $55M |
| SG&A Expense | $93M | $244M |
| Cost of Goods Sold | – | $81M |
Dividend & Shareholder Information
| Metric | BDSX | CSTL |
|---|---|---|
| Shares Outstanding | 11M | 31M |
| EPS Growth | – | -328.3% |
BDSX vs CSTL: stock comparison and AI forecast
Which is bigger, BDSX or CSTL?
CSTL is 4.8 times larger than BDSX by market capitalization ($1.09B against $227M).
Which stock performed better over the last six months, BDSX or CSTL?
Over the last six months CSTL returned +44.4% and BDSX +43.3%.
Which one does Intratio's AI model rank higher, BDSX or CSTL?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.